🇺🇸 FDA
Pipeline program

20mg Febuxostat

XYFY2017-KL043-01

Approved small_molecule active

Quick answer

20mg Febuxostat for Hyperuricemia is a Approved program (small_molecule) at First Tracks Biotherapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
First Tracks Biotherapeutics
Indication
Hyperuricemia
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials